Christopher-Michael Gale
Beth Israel Deaconess Medical Center
1 paper in the Anchorcite directory, published in 2007, cited 4,559 times in total.
Research topics
- HER2/EGFR in Cancer Research · 1 paper
- Cancer Genomics and Diagnostics · 1 paper
- Lung Cancer Treatments and Mutations · 1 paper
Frequent co-authors
- Jeffrey A. Engelman · 1 paper
- Kreshnik Zejnullahu · 1 paper
- Tetsuya Mitsudomi · 1 paper
- Youngchul Song · 1 paper
- Courtney Hyland · 1 paper
- Joon Oh Park · 1 paper
- Neal Ian Lindeman · 1 paper
- James G. Christensen · 1 paper
Papers
- MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 SignalingScience · 2007 · 4,559 citations
The epidermal growth factor receptor (EGFR) kinase inhibitors gefitinib and erlotinib are effective treatments for lung cancers with EGFR activating mutations, but these tumors invariably develop drug resistance. Here, we describe a gefitinib-sensitive lung cancer cell line that developed resistance…
Metadata from OpenAlex (CC0).